论文部分内容阅读
目的对小儿哮喘治疗采用普米克气雾剂结合孟鲁司特的效果进行观察。方法随机选取我院2012年10月至2013年10月接收治疗的88例小儿哮喘患儿,并将其随机分成两组,其中对照组患儿单纯实施普米克气雾剂治疗,观察组患儿在此基础上,结合孟鲁司特治疗,最后对两组患儿的临床治疗效果进行分析。结果观察组患儿治疗后的临床指标改善情况,明显优于对照组,二者差异显著,比较具有统计学意义(P<0.05);观察组患儿的临床治疗总有效率为88.6%,对照组仅为68.2%,二者差异显著,比较具有统计学意义(P<0.05)。结论采用普米克气雾剂联合孟鲁司特治疗小儿哮喘,效果显著,具有可行性,值得在临床中推广使用。
Objective To observe the effect of Pulmicort aerosol combined with montelukast on pediatric asthma treatment. Methods A total of 88 children with asthma who received treatment from October 2012 to October 2013 in our hospital were selected randomly and divided into two groups at random. Among them, the children in the control group were treated with Pulmicort aerosol alone and the children in the observation group On this basis, combined with montelukast treatment, the final treatment of children in two groups were analyzed. Results The improvement of clinical indexes in observation group was significantly better than that in control group, with significant difference between the two groups (P <0.05). The total effective rate of clinical treatment in observation group was 88.6% Group was only 68.2%, the difference was significant, more statistically significant (P <0.05). Conclusion Pulmicort aerosol combined with montelukast treatment of pediatric asthma, the effect is significant and feasible, it is worth in the clinic to promote the use of.